kotak-logo
Products
Platform
Research
Market
Learn
Partner
Support
IPO

V

Venmax Drugs & Pharmaceuticals Share Price

27.45
-0.75 (-2.66%)
VENMAX • 09 Feb, 2026 | 03:29 PM

10Y Annualised Return

26.47%

The current prices are delayed, login or Open Demat Account for live prices.

Venmax Drugs & Pharmaceuticals Stock Performance

1W Return16.51
1Y Return-5.61
Today's Low25.5
Prev. Close28.20
Mkt Cap (Cr.)24.11
1M Return3.82
3Y Return556.70
52-Week High36.96
Open28.90
PE Ratio70.38
6M Return-5.90
Today's High28.9
52-Week Low17.51
Face Value10

Venmax Drugs & Pharmaceuticals Company background

Founded in: 1988
Venmax Drugs Pharmaceuticals Limited, (VDPL) was initially incorporated as Private Company as Yenkay Medico Private Limited, on 28 September, 1998. The Company thereafter changed its name to Yenkey Drugs Pharmaceuticals Private Limited on 18 January, 1995. It became a Public Limited Company on February 3, 1995 as Yenkey Drugs Pharmaceuticals Limited. Finally, the Company changed its name to Venmax Drugs Pharmaceuticals Limited on April 13, 2009. For the past six months, Company focused on establishing chain of Medical Stores with a brand name as Ananya Pharma under the Venmax Drugs Pharma Limited, with the backing support of Formulations plant (Suzichem Labs). At present, Company is engaged in the business of pharmaceutical products, drug intermediaries APIs etc. The Company is developing the oncology products in RD. Planning to establish a manufacturing UNIT with cGMP facility at Pharma Cluster at Hyderabad, to meet the export demand.

Venmax Drugs & Pharmaceuticals Share Price Today


As of 9 Feb 2026, Venmax Drugs & Pharmaceuticals share price is ₹27.4. The stock opened at ₹28.9 and had closed at ₹28.2 the previous day. During today’s trading session, Venmax Drugs & Pharmaceuticals share price moved between ₹25.50 and ₹28.90, with an average price for the day of ₹27.20. Over the last 52 weeks, the stock has recorded a low of ₹17.51 and a high of ₹36.96. In terms of performance, Venmax Drugs & Pharmaceuticals share price has declined by 5.9% over the past six months and has declined by 1.05% over the last year.
Read More
View details of Market Depth

Venmax Drugs & Pharmaceuticals Fundamental

Market Cap (in crs)

24.11

Face Value

10

Turnover (in lacs)

2.67

Key Metrics

Qtr Change %
25.73% Fall from 52W High
-4.1
Dividend yield 1yr %
0

Venmax Drugs & Pharmaceuticals Shareholding Pattern

Promoter
15.1%
Public
84.9%

Venmax Drugs & Pharmaceuticals Technical Analysis

Moving Averages Analysis
27.45
Current Price
Bullish Moving Averages
16
Bearish Moving Averages
0
Day EMA5
26.80
Day EMA10
26.10
Day EMA12
26.00
Day EMA20
25.90
Day EMA26
26.00
Day EMA50
26.30
Day EMA100
26.40
Day EMA200
25.10
Delivery & Volume
Loading chart...

Day

87.70%

Week

86.50%

Month

94.20%

Delivery & Volume

27.28
Pivot
Resistance
First Resistance
29.07
Second Resistance
30.68
Third Resistance
32.47
Support
First Support
25.67
Second support
23.88
Third Support
22.27
Relative Strength Index
57.26
Money Flow Index
41.90
MACD
0.04
MACD Signal
-0.35
Average True Range
2.53
Average Directional Index
16.30
Rate of Change (21)
7.02
Rate of Change (125)
9.15
Compare

Venmax Drugs & Pharmaceuticals Latest News

09 FEB 2026 | Monday
07 FEB 2026 | Saturday
07 FEB 2026 | Saturday

Please be aware that Venmax Drugs & Pharmaceuticals stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account